NCT03059953View on ClinicalTrials.gov

A Study of Treatment With APRemilast in Moderate psoriAsIS in Real Life clinicAL Practice (The 'APRAISAL' Study)

CompletedOBSERVATIONAL
Enrollment

302

Participants

Timeline

Start Date

April 7, 2017

Primary Completion Date

April 6, 2018

Study Completion Date

April 24, 2019

Conditions
Moderate Plaque Psoriasis
Trial Locations (1)

Unknown

401 General Military Hospital, Athens

Sponsors

Collaborators (1)

Celgene
All Listed Sponsors
collaborator

Celgene

INDUSTRY

lead

Genesis Pharma S.A.

INDUSTRY